All In Biotech

Drug Trial Radar · NCT00839800

Study to Investigate the Efficacy of Symbicort® SMART.

A Comparison of Symbicort® SMART (160/4.5μg) and Symbicort® Turbuhaler 160/4.5 μg, Plus Terbutaline Turbuhaler 0.4 mg as Needed, for Treatment of Asthma - a 12-month, Randomized, Double-blind, Parallel Group, Active-controlled, Multinational Phase III Study in Asthmatic Patients From 16 Years

Last checked: Nov 20, 2026Latest source record: Nov 30, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,091 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,091

Actual

Start

Feb 2009

Primary completion

Feb 2011

Study completion Feb 2011

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Feb 10, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to compare the efficacy of Symbicort SMART (Symbicort Turbuhaler 160/4.5μg, one inhalation twice daily plus as needed) with Symbicort Turbuhaler 160/4.5μg, one inhalation twice daily plus terbutaline Turbuhaler 0.4 mg as needed, as asthma therapy

Conditions

  • Asthma

Interventions

  • Symbicort TurbuhalerDrug

    160/4.5 µg

  • Terbutaline TurbuhalerDrug

    0.4 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Percentage of Participants Who Had Experienced Asthma Exacerbation(s) at the End of the StudyTime frame: week 52

Locations

109 sites in 12 countries. Site status is shown where the registry gives one.

  • Research Site

    Ciudad de Buenos Aires, Argentina

  • Research Site

    Buenos Aires, Argentina, Argentina

  • Research Site

    Capital Federal, Buenos Aires, Argentina

  • Research Site

    Mar del Plata, Buenos Aires, Argentina

  • Research Site

    Monte Grande, Buenos Aires, Argentina

  • Research Site

    Quilmes, Buenos Aires, Argentina

  • Research Site

    Rosario, Santa Fe Province, Argentina

  • Research Site

    Santa Fe, Santa Fe Province, Argentina

  • Research Site

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Research Site

    Porto Alegre, Brasil, Brazil

  • Research Site

    Belo Horizonte, Minas Gerais, Brazil

  • Research Site

    Juiz de Fora, Minas Gerais, Brazil

  • Research Site

    Rio de Janeiro, Rio de Janeiro, Brazil

  • Research Site

    Porto Alegre, Rio Grande do Sul, Brazil

  • Research Site

    Florianópolis, Santa Catarina, Brazil

  • Research Site

    Santo André, São Paulo, Brazil

  • Research Site

    Chongqing, China

  • Research Site

    Guangzhou, China

  • Research Site

    Nanjing, China

  • Research Site

    Qingdao, China

  • Research Site

    Shanghai, China

  • Research Site

    Xi'an, China

  • Research Site

    Shenyang, Liaoning, China

  • Research Site

    Hangzhou, Zhejiang, China

  • Research Site

    Tres Ríos, Cartago Province, Costa Rica

  • Research Site

    Barrio San Bosco, Provincia de San José, Costa Rica

  • Research Site

    Budapest, Hungary

  • Research Site

    Cegléd, Hungary

  • Research Site

    Debrecen, Hungary

  • Research Site

    Deszk, Hungary

  • Research Site

    Gyula, Hungary

  • Research Site

    Nyíregyháza, Hungary

  • Research Site

    Százhalombatta, Hungary

  • Research Site

    Noida, India

  • Research Site

    Bangalore, Karnataka, India

  • Research Site

    Mangalore, Karnataka, India

  • Research Site

    Mysore, Karnataka, India

  • Research Site

    Trivandrum, Kerala, India

  • Research Site

    Mumbai, Maharashtra, India

  • Research Site

    Nagpur, Maharashtra, India

Showing 40 of 109 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.